Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. [electronic resource]
- Cancer research Jun 1999
- 2596-601 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-5472
Animals Anticarcinogenic Agents--pharmacology Cattle Cell Division--drug effects Cyclin-Dependent Kinase Inhibitor p21 Cyclins--drug effects Endothelium, Vascular--cytology G2 Phase--drug effects Nitric Oxide Synthase--drug effects Nitric Oxide Synthase Type III Pulmonary Artery--cytology Resveratrol S Phase--drug effects Stilbenes--pharmacology Tumor Suppressor Protein p53--drug effects